Piepoli M, Abreu A, Albus C, et al. Update on cardiovascular prevention in clinical practice: a position paper of the European Association of Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol 2020; 27: 181–205.
2.
Piepoli MF, Hoes AW, Agewall S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315–2381.
3.
ArnettDKBlumenthalRSAlbertMA, et al.2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation2019; 140: e563–e595.
4.
ArnettDKBlumenthalRSAlbertMA, et al.2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol2019; 74: e177–e232.
5.
LiYPanAWangDD, et al.Impact of healthy lifestyle factors on life expectancies in the US population. Circulation2018; 138: 345–355.
6.
ArnettDKBlumenthalRSAlbertMA, et al.2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation2019; 140: e596–e646.
7.
DehghanMMenteAZhangX, et al.Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet2017; 390: 2050–2062.
8.
Lear SA, Hu W, Rangarajan S, et al. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study. Lancet 2017; 390: 2643–2654.
9.
Garnvik LE, Malmo V, Janszky I, et al. Physical activity modifies the risk of atrial fibrillation in obese individuals: the HUNT3 study. Eur J Prev Cardiol 2018; 25: 1646–1652.
10.
VolaklisKAThorandBPetersA, et al.Physical activity, muscular strength, and polypharmacy among older multimorbid persons: results from the KORA-Age study. Scand J Med Sci Spor2018; 28: 604–612.
11.
BlairSNKampertJBKohlHW3rd, et al.Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA1996; 276: 205–210.
12.
PaffenbargerRSJrHydeRTWingAL, et al.The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med1993; 328: 538–545.
13.
SattelmairJPertmanJDingEL, et al.Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation2011; 124: 789–795.
14.
KnowlerWCFowlerSEHammanRF, et al.10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet2009; 374: 1677–1686.
15.
WingRRBolinPBrancatiFL, et al.Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med2013; 369: 145–154.
16.
O’ConnorCMWhellanDJLeeKL, et al.Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA2009; 301: 1439–1450.
17.
KontisVCobbLKMathersCD, et al.Three public health interventions could save 94 million lives in 25 years. Circulation2019; 140: 715–725.
18.
KeteyianSJLeiferESHouston-MillerN, et al.Relation between volume of exercise and clinical outcomes in patients with heart failure. J Am Coll Cardiol2012; 60: 1899–1905.
19.
HammanRFWingRREdelsteinSL, et al.Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care2006; 29: 2102–2107.
20.
Linseisen J, Peters A, Pischon T, et al. The German National Cohort: aims, study design and organization. Eur J Epidemiol 2014; 29: 371–382.
21.
TikkanenEGustafssonSIngelssonE. Associations of fitness, physical activity, strength, and genetic risk with cardiovascular disease: longitudinal analyses in the UK Biobank Study. Circulation2018; 137: 2583–2591.
22.
SaidMAVerweijNvan der HarstP. Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK Biobank Study. JAMA Cardiol2018; 3: 693–702.
23.
Di AngelantonioEKaptogeSWormserD, et al.Association of cardiometabolic multimorbidity with mortality. JAMA2015; 314: 52–60.
24.
SuchyCMassenLRognmoO, et al.Optimising exercise training in prevention and treatment of diastolic heart failure (OptimEx-CLIN): rationale and design of a prospective, randomised, controlled trial. Eur J Prev Cardiol2014; 21: 18–25.
25.
BowenTSHerzCRolimNPL, et al.Effects of endurance training on detrimental structural, cellular, and functional alterations in skeletal muscles of heart failure with preserved ejection fraction. J Card Fail2018; 24: 603–613.
26.
SimI. Mobile devices and health. N Engl J Med2019; 381: 956–968.
27.
PerezMVMahaffeyKWHedlinH, et al.Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med2019; 381: 1909–1917.
